Dr. R. Karl Knight is President of PharmiKom Inc. and a physician specializing in pharmaceutical medicine. He brings 15 years experience in the industry in major American and British pharmaceutical companies from both sides of the Atlantic. Before founding PharmiKom Inc. in 1997, he was Vice President in Worldwide Strategic Product Development at SmithKline Beecham Pharmaceuticals in the United States. Dr. Knight is a graduate of the Welsh National School of Medicine, Cardiff, Wales, UK and a Member of the Royal College of Physicians. Prior to entering the pharmaceutical industry he trained in rheumatology.